BENEFITS DIGEST

Aramark, Whirlpool, Grainger, Kraft Heinz, Ralph Lauren and Sterling Jewelers, with their health plans, accuse UnitedHealth affiliates of mishandling claims in plans the employers fund themselves. The allegations include undisclosed fees, favoring affiliates, and cross-plan offsets, meaning amounts owed on one plan’s claims were used to recover money associated with another plan without crediting theirs. The 12-count complaint seeks repayment, surrender of allegedly improper gains and access to claims records. The public version is heavily redacted, so the employers allege losses in the millions without a quantified total. Everything remains contested, including whether UnitedHealth acted as a fiduciary, but the case puts the sponsor’s right to see and audit claims data squarely in play.

Johnson & Johnson filed a supplemental-authority letter telling the Third Circuit that the Supreme Court’s denial of review in Aldridge leaves intact the Sixth Circuit’s limit on monetary relief for fiduciary-breach claims like the drug-pricing fee suit against it. The Supreme Court’s refusal to hear the case settles nothing on the merits and isn’t an endorsement of the lower court’s reasoning. The filing is advocacy in a pending appeal, and the Third Circuit hasn’t ruled.

OIRA’s docket shows the Labor Department’s rule titled Improving Transparency into Pharmacy Benefit Manager Fee Disclosure concluded review on October 20 and cleared with changes made during the review, which the docket records as consistent with change. The [January proposal](https://www.federalregister.gov/documents/2026/01/30/2026-01907/improving-transparency-into-pharmacy-benefit-manager-fee-disclosure) would require disclosure of the direct and indirect compensation pharmacy benefit managers receive, so that group health plan fiduciaries can judge whether their PBM contracts are reasonable, and the rule’s [Unified Agenda entry](https://www.reginfo.gov/public/do/eAgendaViewRule?pubId=202510&RIN=1210-AB37) carries the fuller description. The cleared text is not yet public, so what the rule now says awaits Federal Register publication.

Thompson Hine unpacks a California [complaint](https://digest.theinnerfirm.com/docs/kreutzmann-v-cigna-complaint-2026-10-12.pdf) alleging that Cigna charged a self-funded plan percentage-based shared-savings fees of up to 29% on ground-ambulance bills it simply did not pay in full, in one example paying $386.77 of a $3,644.91 bill while the participant faced collection for the balance the fee treated as savings. The participant pleads fiduciary breach and self-dealing. The firm’s practical advice runs to reviewing fee formulas, payment-in-full assurances, reporting, and audit rights in administrative services agreements, and notes the employer is not a defendant. The allegations are untested, and functional fiduciary status is exactly what the case will contest.

A September Milliman study of group commercial claims from 2022 through 2024 puts data behind a question employers increasingly ask about midlife women’s health benefits. About 1.3 million American women enter menopause each year, yet the study found only about 25 percent of commercially insured women ages 40 to 64 carry a menopause diagnosis, which the authors read as underdiagnosis. Treatment doesn’t line up with diagnosis either, since some women receive hormone therapy with no menopause diagnosis on file while diagnosed women often go untreated, and women with a diagnosis show higher rates of other conditions. Before buying specialized menopause benefits, employers should look at what their claims data says about the care employees receive. But a missing diagnosis code doesn’t prove that care was denied.

An associate at AmeriBen, the company administering the plaintiffs’ employer health plan, emailed a spreadsheet of members’ claims data, names, providers, dates of service and amounts billed, to other plan members. The district court dismissed the resulting class action, finding no concrete injury. The Ninth Circuit reversed in a published opinion, holding that unauthorized disclosure of sensitive health information entrusted to a company is itself the injury. Congress’s judgment in HIPAA reinforced the point, since even mundane-looking line items can reveal a psychiatrist visit or a fertility clinic. The ruling allows the patients’ suit to proceed without requiring them to show that the disclosure caused financial loss, and it matters to sponsors because the defendant administers employer health plans across the country.

Judge William Orrick allowed claims over denied benefits and failures to protect plan participants to proceed against both Blue Shield and its mental health subcontractor, Magellan. Blue Shield also faces a claim that its mental health network offered worse access than its medical network. For employees in plans outside ERISA, the court allowed claims to enforce their employers' contracts with Blue Shield. Magellan won dismissal of several state-law claims on different grounds, including that participants couldn't enforce its contract with Blue Shield. The plaintiffs can revise the dismissed claims. The ruling allows the surviving claims to move forward; it doesn't establish that either company broke the law.

Chief Judge Timothy Brooks declined a magistrate's recommendation and entered judgment for a participant, holding that UnitedHealthcare abused its discretion when it refused to classify oral surgery after an accident as emergency care because the surgery happened more than a week after the injury, in May 2020, when pandemic restrictions delayed treatment. The plan's own pandemic provision and its promise that the initial emergency visit will be covered could not be read, the court held, to mean only the initial visit, when emergency room doctors had documented the need for immediate surgery. The classification left the participant with $33,827 in out-of-pocket costs for pre-operative services and $73,068 for the surgery, and the court ordered the services covered in network, with a fee motion pending. Administrators holding discretion clauses should note the lesson: discretion exercised against the plan's own words, in circumstances the plan itself anticipated, doesn't survive review.

The out-of-network payment fight can run in either direction, and in this case the insurer was the one suing. United Healthcare sued three Georgia emergency medicine groups affiliated with TeamHealth in 2023, alleging they overcharged patients in employer-sponsored plans for out-of-network services and arguing that ERISA plan terms, not the providers' billed charges, control what gets paid. Hall Benefits Law reports the parties have settled on undisclosed terms and the court has closed the case, with nothing decided on the merits.

Illinois providers treated 65 participants of Aisin Manufacturing's self-funded plan after Anthem verified coverage by phone, billed about $895,000, and were paid about $184,000. In Marion HealthCare v. Aisin, their ERISA claims were dismissed because both plan versions bar patients from transferring their right to claim benefits to providers, so the patients' assignments conveyed nothing. The plan's direct-payment clause didn't help; paying providers directly is payment mechanics, not permission to sue.

In Jane Doe v. The Signature Benefits Plan, No. 8:24-cv-02230 (C.D. Cal. Sept. 17, 2026), Chief Judge Dolly M. Gee ordered the plan, self-funded by The Walt Disney Company, to cover a teenager's five-week residential mental health stay at an out-of-network facility. The plan gave the company “full discretion” to decide claims, but the court found no basis to give the same leeway to Evernorth Behavioral Health, the utilization reviewer that made the denial decisions and is “not mentioned anywhere in the Plan,” so it reviewed the record fresh. The court found that the denials used the wrong standards. The initial letter said the boy was not at “imminent risk” of serious self-harm, a test the applicable guidelines don't contain. They ask instead about persistent thoughts of suicide or self-harm that lower levels of care can't manage, which the court found the record supported. The independent external reviewer applied a definition of medical necessity “found nowhere in the Administrative Record.” The mother won benefits and interest and may seek attorney fees, and the parties must work out the amount owed. For sponsors, the case raises two questions. Has the actual decision maker been given discretion, and do denial letters apply the right criteria?

Arkansas has required pharmacy benefit managers to reimburse pharmacies at least the national average acquisition cost of a drug since 2015; a law passed last year finally gave pharmacies the right to sue over violations, with statutory damages up to $10,000 per violation. Twelve independent Arkansas pharmacies have now become the first to use it, filing in Missouri state court, Express Scripts' home turf. They say they documented about 48,300 underpaid prescriptions between August 2025 and March 2026, likely an undercount given their limited view into claims data, and the complaint does not mince words: “Express Scripts' failure to comply with Arkansas law is not a technological challenge; it is a business decision.” Express Scripts says it pays competitive rates and will defend itself. One to watch for plan sponsors as states keep building private enforcement mechanisms against PBMs.

Four practitioners answer one question and produce a workable audit checklist for health plan governance. The starting recognition: overseeing an ERISA health plan is not simply an HR function, and health plan oversight can carry fiduciary responsibilities for the people performing it, including HR staff. From there the advice gets concrete. Adopt a written committee charter and train the members. Read the plan's contracts and know how every service provider is paid. Make vendor oversight continuous, from compensation disclosures and gag clause review to periodic RFPs, and reframe the standard from “are we happy with our vendor” to “can we demonstrate that retaining this vendor is a prudent decision.” Get claims and pharmacy data and act on it. Keep a compliance calendar spanning the Form 5500, gag clause attestations, RxDC reporting and parity. Prudence is largely about process: keep a record of the information considered and the reasons for the decision.

Segal urges health plan fiduciaries to include vendors' use of AI in their oversight, warning about the risks of deploying tools without adequate review or participant protections. Its read on the technology is sober. The most consistent measurable benefits so far are administrative, while generative chatbots, the most visible use, have been shown to enable harmful behaviors in vulnerable users, against what Segal calls the lack of a clear regulatory framework for AI tools in mental health. The practical takeaway is four steps: audit vendors' use of AI, require clear disclosure of participant-facing AI, adopt ongoing governance practices, and verify the safety guardrails. A fuller version with a risk table by AI type and questions to put to vendors runs in this quarter's Benefits Quarterly.

The first firm commentary on Monday's One Thing, written from the claimant side. The walkthrough of Glaud v. NFL Player Disability and Survivor Benefit Plan confirms that fiduciary status is a threshold prerequisite to the breach claims and that the medical advisory physicians decided only the medical issues submitted to them while the board kept final authority. The takeaway for claimants is blunt. Medical reviewers cannot be sued for breach of fiduciary duty merely for issuing unfavorable opinions, even in a pattern, unless the professional exercises an unusual degree of influence over the plan. The benefits claim against the plan itself is where the case now lives.

Health plan governance is getting the 401(k) treatment. Benefits attorneys and consultants walk through what sponsors should be doing now: negotiate rebate pass-throughs and oversight rights into PBM contracts before signing, benchmark per-member fees, and collect compensation disclosures from every vendor taking $1,000 or more a year from the plan. The clock behind the advice is the Consolidated Appropriations Act of 2026. Its ERISA-fiduciary provisions treat PBMs as covered service providers and require spread pricing out of contracts by August 1, 2029.

Claims data confirming what benefits teams have suspected: in the group commercial population from 2022 through 2024, only about a quarter of women ages 40 to 64 carried a menopause diagnosis, and treatment often ran misaligned with documentation—therapy without a recorded diagnosis, diagnoses without corresponding care. Women with documented menopause showed higher rates of selected comorbid conditions, which is why the underdiagnosis matters for plan spend as much as for outcomes.

Summary judgment for the employer, on facts every self funded sponsor should file away. BCI served as the plan's claims administrator and named ERISA claim fiduciary while also writing its stop-loss coverage—a conflict the court called actual once a newborn participant's second excess claim of roughly $1.4 million arrived near the coverage window's close. BCI's own account team had flagged the infant as a high cost claimant more than three months before the window shut, and its underwriting director conceded the company had retroactively modified stop-loss contracts before. The court held the duty of loyalty required expediting or covering the claim, refused to let undisclosed Blue Cross association manuals absolve a fiduciary under ERISA's anti exculpation clause, and awarded Scentsy an Amara surcharge for the amount it paid out of pocket.

With salary budgets flat and AI reshaping rewards, employers lean on transparency, career growth, and benefits to retain talent.

For more than a decade, the Department of Labor’s participant fee disclosure regulation under ERISA Section 404(a)(5) has been promoted as the cornerstone of transparency in defined contribution plans.

Proposed rule requiring PBMs servicing group health plans to disclose direct and indirect compensation to plan fiduciaries, extending the ERISA §408(b)(2) service-provider fee-disclosure framework